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Abstract 13 
Microsporidia may be emerging infectious diseases (EIDs) in bumblebees. Two drivers – 14 
commercial bumblebees and managed honey bees – have been identified as possible sources 15 
of pathogen spillover. In addition, declines in bumblebee populations may have led to lower 16 
genetic diversity and subsequent higher susceptibility to infection, enabling microsporidia to 17 
increase in prevalence. There is strong evidence for relatively recent increases in the 18 
prevalence of Nosema bombi in North America. However, the lack of definitive data on 19 
spillover by microsporidia, in North America or elsewhere, makes it difficult to identify the 20 
causes of such increases. Phylo-genomic studies are urgently needed to identify the global 21 
population structure of microsporidia in bumblebees, and thus identify the source of current 22 
and future epidemics. 23 
 24 
Microsporidia in bumblebees – where? when? why? how? 25 
Microsporidia (see Glossary) were first recorded in bumblebees in 1913 [1,2]. Nearly a 26 
century later, they are at the heart of a controversy about the role of emerging infectious 27 
diseases (EIDs) in driving bumblebee declines [3,4]. Bumblebees are important pollinators 28 
across temperate, alpine, and arctic regions for a range of crops and wildflowers [5,6], and so 29 
understanding why they are declining is an important question for the sustainability of 30 
agriculture and natural ecosystems [7].  A recent study [8] provided intriguing evidence that 31 
microsporidia might be involved in these declines. However, determining whether 32 
microsporidian infections and disease have become more common in bumblebee populations, 33 
with concomitant higher impacts, as the emerging infectious disease hypothesis requires, is 34 
complicated by underlying uncertainties about the identity, diversity, and impact of these 35 
pathogens. Here, I assess what is known about microsporidia in bumblebees, and identify 36 
issues that are holding back our understanding of this host-pathogen interaction. 37 
 38 
The diversity of Microsporidia in bumblebees 39 
An array of microsporidia, including Nosema apis, Nosema bombi, Nosema ceranae, Nosema 40 
portugal, Nosema thomsoni, Tubulinosema pampeana, and Vairimorpha spp., have been 41 
shown or suggested to infect bumble bees [1,2,9-12]. Consequently, assessing prevalence, 42 
and possible changes in prevalence, requires accurate identification of the infectious agent. 43 
Prior to the development of molecular tools [13], nearly all microsporidian infections in 44 
bumblebees were identified as N. bombi (Table 1). Best practice at the time meant that 45 
identifications should have been based on the presence of spores (and other life-stages) in the 46 
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Malpighian tubules, the main site of infection identified in the original description of the 47 
species [2]. However, many studies fail to detail their screening method for Nosema in 48 
sufficient detail, and combined with the controversy about whether N. apis can infect 49 
bumblebees [1,14,15], and the recent discovery of N. ceranae and T. pampeana infections 50 
[9,11], this makes the species identification in many earlier studies uncertain (Table 1, Table 51 
2). Since the development of molecular tools it has been possible to combine dissection and 52 
microscopy with molecular screening, to produce definitive accounts of prevalence [e.g., 53 
8,16,17]. However, at the same time the use of molecular screening on its own has resulted in 54 
studies that measure the presence and absence of pathogen DNA, without determining if this 55 
represents a true infection [10,12,18-20](Table 1, Table 2). As false positives can be 56 
generated by pathogen spores that are being vectored, or that have been ingested, or by mis-57 
priming during PCR reactions, interpretation of prevalence based on molecular screening 58 
alone is problematic. 59 
 60 
In terms of assessing prevalence in the field, N. bombi [2,13,21], N. ceranae [9,22], and T. 61 
pampeana [11] are the only microsporidia that have been definitively shown to infect wild 62 
bumblebees (Figure 1). Whether N. bombi as known today is the same as the original 63 
microsporidian described under this name [2], and reported in subsequent microscopy studies, 64 
is unlikely to be resolved, although descriptions of tissue specificity make this likely. 65 
Hereafter, I will assume that the species identification given by authors for microsporidian 66 
infections is accurate, whilst bearing in mind the caveats detailed above. 67 
 68 
Impact of microsporidians in bumblebees 69 
One reason that N. bombi and N. ceranae raise concern as potential causal agents of EIDs is 70 
their apparently high virulence. Obviously, an EID with low impact is unlikely to be a driver 71 
of host population declines. Whittington and Winston [23] reported the suggestion, by 72 
bumblebee suppliers, that N. bombi may have been behind the collapse of commercial B. 73 
occidentalis breeding in the late 1990s. However, in a correlational experiment they found no 74 
impact of N. bombi on commercially-sourced infected colonies [23], which would appear to 75 
contradict this claim. In contrast, recent experimental studies have demonstrated significant 76 
negative impacts on individual health and colony-level reproductive fitness by N. bombi [24-77 
27], and on individuals by N. ceranae [28, but see 19]. All of these studies have been 78 
conducted on either Bombus lucorum or Bombus terrestris, two common Palearctic species, 79 
with the latter being one of the main species produced commercially for pollination services 80 
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[29]. Interestingly, the virulence of N. bombi appears to vary across these two host species 81 
[27]. Whether impacts vary across the other ~250 species of bumblebee remains to be 82 
determined, but given their wide range in life history, this seems likely. In addition, whether 83 
commercial rearing has selected for more virulent strains of the parasite, or changes in 84 
tolerance/susceptibility in the host, remains an open question. The impact of T. pampeana has 85 
yet to be investigated. In addition, how or if impacts at the level of individual colonies 86 
translate into changes in inter-annual population dynamics in the field remains unexplored. 87 
 88 
Patterns of prevalence of microsporidians in bumblebees 89 
Bumblebees, like other eusocial insects, comprise three classes of individuals – males, queens 90 
and workers – and studies have suggested variation across these in the prevalence of N. bombi 91 
[reviewed by 30]. However, measuring prevalence is not trivial. Queens are available for 92 
sampling for a relatively short period after hibernation, and thus spot samples are likely to 93 
produce a relatively good measure of prevalence. In contrast, workers and males are produced 94 
over a period of months. The seasonal progression of the annual Nosema epidemic, both 95 
within [31] and among [32] colonies, poses a challenge to generating a meaningful 96 
assessment of prevalence in workers or males and making comparisons across species or 97 
years. Nevertheless, most studies have focused on workers as they are more abundant, and 98 
collecting them puts less pressure on declining bumblebee populations (Figure 2). 99 
 100 
The concept of microsporidians as causal agents of EIDs lies behind the question of whether 101 
microsporidian infection and disease, in particular N. bombi and N. ceranae, is increasing in 102 
bumblebees. Thorp and Shepherd 103 
[www.xerces.org/Pollinator_Red_List/Bees/Bombus_Bombus.pdf] suggested, based on the 104 
putatively Nosema-driven collapse of commercial breeding for B. occidentalis, and 105 
concomitant declines in native bumblebee populations in North America, that N. bombi might 106 
be the causal agent of an EID in North America. This was backed up by reports of high N. 107 
bombi prevalence in declining bumblebee species in the USA [16]. The basis for similar 108 
interpretions of N. ceranae rely on an association of its presence in UK bumble bees with its 109 
presence in European honey bees [19], and the idea that N. ceranae is also driving an EID in 110 
the European honey bee, Apis mellifera [reviewed in 33].  111 
 112 
If commercial distribution and use of bumblebees for pollination is a driver of microsporidian 113 
emergence in wild populations (either through spillover or spillback), one way to assess this 114 
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(albeit crudely) is to examine datasets collected pre- and post-commercialisation. N. bombi, 115 
as identified by microscopy, was present in Europe (Denmark, Switzerland, UK), New 116 
Zealand, and North America, with prevalences varying from 0-100% in spring queens, 0-55% 117 
in workers, and 0-50% in males, prior to commercialisation [reviewed by 30](Figure 2). 118 
Studies post-commercialisation in Europe [34] and North America [8,16,35-38] show similar 119 
prevalence ranges in queens and workers (Figure 2). Given that N. bombi has largely been 120 
suggested to be an EID in North America 121 
[www.xerces.org/Pollinator_Red_List/Bees/Bombus_Bombus.pdf], a fairer comparison 122 
might be between studies in North America pre- and post-commercial production of 123 
bumblebees. Unfortunately, only two studies of N. bombi from North America prior to 124 
commercialisation exist [39,40]. Interestingly, both report low levels of infection (<5% in 125 
[39]). 126 
 127 
Can space be a substitute for time? If microsporidians cause EIDs, then they should exibit 128 
higher prevalence in areas nearer to the proposed source population (commercial bumble bees 129 
for N. bombi, managed honey bees for N. ceranae). Colla et al. [41] found N. bombi in 14% 130 
of bumble bees next to a Canadian greenhouse using commercial B. impatiens, as opposed to 131 
<4% of bees at non-greenhouse sites. However, a second greenhouse site had no infected 132 
bees, making this result hard to interpret. In a larger-scale study, Murray et al. [42] showed a 133 
gradual decline of N. bombi prevalence in male B. terrestris as distance from Irish strawberry 134 
farms using commercial bumble bees increased (prevalence in workers showed no trend in 135 
either direction). This could be interpreted as increased transmission, and thus prevalence of 136 
the microsporidian near commercial operations (that is, pathogen spillover or spillback), or 137 
alternatively as commercial males from infected colonies exhibiting philopatry (although 138 
current evidence of male dispersal argues against this [43]). Whitehorn et al. [44] found 139 
generally low prevalence of N. bombi in bumblebee workers around Scottish fruit farms, 140 
irrespective of whether they were using commercial bumblebees or not, a result reflected in a 141 
study of fruit farms in England [45]. One reason for these contrasting results may be variation 142 
across studies in the time elapsed between the placement of commercial colonies and the 143 
sampling of wild bees for prevalence, as transmission is a dynamic and potentially rapid 144 
process. Overall, there is no definitive evidence that N. bombi infections are higher in areas 145 
where managed bumblebees are present. An important, and currently unanswered question 146 
here is what the actual levels of microsporidian infection in commercial colonies are. 147 
Graystock et al. [46] found both N. bombi and N. ceranae infections in commercial colonies 148 
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ordered between 2011-2012 from three producers in Europe, while Sachman-Ruiz et al [47] 149 
found N. bombi in commercial colonies in Mexico (Table 2). Since then, at least some 150 
producers have responded by improving their in-house screening protocols with the aim of 151 
producing disease-free colonies. We currently lack knowledge of microsporidian levels in 152 
commercial colonies at a global scale, which is essential for understanding potential current 153 
and future EID threats. 154 
 155 
Data outside N. bombi are scarce. Fürst et al [19] showed that, in areas with relatively low N. 156 
ceranae prevalence, patterns in bumblebees in the UK match those of honey bees, suggesting 157 
spillover from honeybees to bumblebees of this microsporidian. However, this pattern 158 
disappeared at higher levels of infection. Finally, Graystock et al. [45] found that N. ceranae 159 
prevalence increased away from greenhouse sites that were not using commercial 160 
bumblebees. No obvious explanation for this pattern exists. Further work is needed to show 161 
whether N. ceranae actively passes from honey bees to bumblebees in the field, and whether 162 
this in turns leads to higher prevalence in bumblebees. 163 
 164 
The most obvious way to address whether microsporidia are emerging in bumblebees is to 165 
look at time series data, and a study doing this for N. bombi has recently been published. 166 
Cameron et al. [8] used museum specimens to screen North American bumblebee species that 167 
had previously been identified as in sharp decline and with current high prevalence levels of 168 
N. bombi [16]. They found a significant increase in prevalence of N. bombi across five 169 
species, occurring in the mid- to late-1990s [8]. This matches the timescale of decline in these 170 
species [16], and thus could be argued to be indicative of an EID. However, before drawing 171 
such a conclusion, the next question has to be, where did the N. bombi infecting these 172 
declining hosts come from? And this itself raises the question of genetic variation within 173 
Nosema species and its local and global distribution. 174 
 175 
Genetic variation in Nosema spp. in bumblebees 176 
The first study of genetic variation in N. bombi, using the rRNA gene, found significant 177 
variation (both SNPs and indels), but no evidence that this variation was partitioned among 178 
infections either geographically (across Europe) or across host species [48]. A similar study 179 
in North America identified one more allele of the same gene, but again found no partitioning 180 
of variation across space or species [17]. In contrast to these studies, which only identified N. 181 
bombi infections, Li et al. [10] screened bumblebees from across China using the same gene, 182 
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and identified N. bombi, N. ceranae, four related clusters, and additional Nosema spp.. 183 
However, in the absence of dissection data, it is not clear which of these represent real 184 
infections as opposed to contamination or vectoring. Given the relative frequency of 185 
sequences, it seems likely that Chinese bumblebees were infected by N. bombi, N. ceranae, 186 
and four clusters labelled Nosema A-D. Again, there was no phylogeographic structure in the 187 
presence of these sequences across host species [10]. Further work by Vavilova et al [20] 188 
combined these data with new sequences sampled in Western Siberia (no proof of infection 189 
status was given), suggesting that sequence clusters A-C identified by [10] are closely related 190 
to, or part of N. ceranae. Nosema D, and three new clusters unique so far to Western Siberia 191 
(WSP1-3) belong to the N. bombi clade [20]. In addition to the rRNA gene, this study utilised 192 
the MetAP2 gene to identify sequence variants, stressing the need for a multi-locus approach 193 
to Nosema phylogeography. Again, due to sampling, there were no clear patterns of variation 194 
across host species or geographical location. Cameron et al. [8] used the rRNA gene, 195 
combining sequences from across Europe, North America, and China (taken from [10]), and 196 
largely confirmed the results of [20], despite the sequences from Western Siberia not being 197 
used in their analysis. Interestingly, sequences from European and North American (both 198 
museum and modern) isolates fell almost completely into a single clade, which also contained 199 
sequences from China. Cameron et al. [8] also conducted a genome-wide analysis using 200 
reduced representation genome sequencing. However, this approach still only identified low 201 
levels of variation across sequences, and no differentiation across North American and 202 
European isolates (with most variation occurring within regions). 203 
 204 
What do these genetic data tell us? If we take them at face-value, they provide evidence of 205 
distinct lineages within both N. bombi and N. ceranae, but no evidence of geographical or 206 
host-species structure to their distribution. This, in turn, argues either (i) against 207 
microsporidia causing EIDs, or (ii) for a recent rapid expansion of, or selective sweep within 208 
microsporidian populations across Europe and North America, which could be evidence for 209 
the EID hypothesis. However, sampling issues – in terms of geography, host species, and 210 
identification of real infections - severely limit the conclusions we can draw. To understand 211 
the dynamics of microsporidians in bumblebees, global phylogenomic studies across multiple 212 
host species, with a special focus on areas where commercial bumblebees or honey bees are 213 
not present, are urgently needed. Genomic data may allow the identification of rapid 214 
population expansions, or selective sweeps, both of which would provide evidence that 215 
microsporidia are functioning as EIDs. The rapid spread of N. bombi-infected B. terrestris in 216 
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South America may provide a unique opportunity to determine if and how N. bombi crosses 217 
species barriers and spreads in native bumblebee populations [49]. 218 
 219 
Concluding remarks  220 
Despite recent studies, too many key questions remain unanswered (see Outstanding 221 
Questions). Are commercial bumblebees and honey bees past, present, or future sources of 222 
microsporidian infection for wild bumblebee populations? If so, does this rely on spill-over or 223 
spill-back dynamics? Has selection in commercial breeding operations selected for higher 224 
virulence or transmission in N. bombi. Has the commercial movement of bumblebees and 225 
honey bees homogenised phylogeographic and host-specific patterns in wild microsporidian 226 
populations? How does the virulence of microsporidia vary across host species, and how does 227 
this translate into population-level impacts? These questions call for an array of well-228 
designed field and laboratory experiments, as well as global, host-species-rich phylogenomic 229 
studies. An integral feature of such studies must be the incorporation of 230 
dissection/microscopy techniques to identify the presence of real infections, or the 231 
development of molecular tools that differentiate between presence/absence and actual 232 
infection. As scientists increasingly turn to molecular methods for measuring prevalence, data 233 
quantity cannot be allowed to compromise the essential data quality needed if we are to 234 
understand the dynamics of disease in our wild pollinators. 235 
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Figure legends 414 
Figure 1. Timeline of important events in our understanding of microsporidia in bumble 415 
bees. 416 
 417 
 418 
Figure 2. Reports of microsporidian prevalence pre- and post-commercial use of bumble 419 
bees. Each bar shows the prevalence range found in a specific study for a specific caste of 420 
bumblebee. 421 
 422 
423 
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Table 1. Records of Nosema spp. infection in wild bumblebeesa.  424 
Year Country Microscopy Molecular N. 
apis 
N. 
bombi 
N. 
ceranae 
T. 
pampeana 
Other Definitive 
infectionb 
Reference 
2015 Argentina Yes Yes No - Yes - - Yes [50] 
2014 USA No Yes -d Yes - - - No [51] 
2013 Germany No Yes - Yes - - - No [52] 
2013 Colombia No Yes No No Yes - - No [53] 
2013 Korea Yes Yes No Yes No - - Yes [54] 
2009-13 Argentina Yes Yes - - - Yes - Yes [11] 
2011-13 USA No Yes - Yes - - - No [38] 
2011 USA Yes Yes - Yes - - - Yes [37] 
2011 UK Yes No - Yes - - - Yes [34] 
2011 UK Yes Yes - - Yes - - Yes [28,45] 
2011 UK No Yes Yes Yes - - - No [28,45] 
2010 Uruguay No Yes No No Yes - - Yes [55] 
2004, 10-
12 
Chile No Yes No Yes No - Yes No [12] 
2011 UK No Yes - - Yes - - No [19] 
2010 UK Yes No - Yes - - - No [44] 
2010 USA Yes Yes - Yes - - - No [36] 
2010 UK Yes No - Yes - - - No [56] 
2009 Sweden Yes Yes - Yes - - - No [57] 
2008 Ireland Yes No - Yes - - - No [42] 
2008 China No Yes - Yes Yes - Yes No [10] 
2007-8 Russia No c Yes - Yes - - - No [20] 
2007-8 USA Yes Yes No identification to species given No [58] 
2007-9 USA Yes Yes - Yes - - - Yes [16,17] 
2006-7 USA Yes Yes - Yes - - - Yes [35] 
2006-7 USA Yes No No identification to species level No [59] 
2005 UK Yes No - Yes - - - Yes [60] 
2004-8 Poland, Russia No Yes - Yes - - - No [18] 
2004-5 Canada Yes No - Yes - - - No [41] 
2003-5 Denmark, Sweden Yes No - Yes - - Possibly Yes [61] 
2003 Ireland Yes No - Yes - - - Yes [62] 
2002-3, 8 USA Yes Yes - Yes - - - Yes [63] 
2001 Switzerland Yes No - Yes - - - - [64] 
200? Denmark, Ireland, Netherlands, Sweden, 
Switzerland, UK 
Yes Yes - Yes - - - Yes [48] 
 
 
16 
1998-9 Switzerland Yes No - Yes - - - No [65] 
1996-8 Turkey Yes No - Yes - - - No [66] 
199? New Zealand Yes No - Yes - - - Yes [21] 
1987, 
2005-8 
Argentina Yes Yes - - Yes - - Yes [9] 
1986-7 New Zealand Yes No - Yes - - - No [67] 
197? Canada ? No - Yes - - - ? [39] 
1962 Denmark Yes No - Yes - - - No [68] 
194? Canada Yes No - Yes - - - Yes [38] 
191? UK ? No - Yes - - - ? [69] 
191? UK Yes No - Yes - - - Yes [2] 
aReferences were assessed for methodology, pathogen species identified, and whether this identification could be viewed as definitive (based on 425 
the methods given). bEither correct tissue screened microscopically, or infection shown microscopically and species confirmed molecularly, or 426 
determined molecularly and intensity quantified at levels indicative of infections. cMicroscopy used, but unclear on what specimens and not part 427 
of screening. dAbbreviations:-, species not screened for; ?, lack of data through inability to access report. 428 
 429 
Table 2. Records of Nosema spp. infection in commercial bumblebeesa.  430 
Year Country Microscopy Molecular N. apis N. bombi N. ceranae T. pampeana Other Definitive infectionb Reference 
201? Mexico No Yes - Yes - - - No [47] 
2011-12 UK Yes Yes No Yes Yes - - No [46] 
2011-12 UK Yes Yes No No Yes - - Yes [28,45] 
2011-12 UK No Yes Yes Yes No - - No [28,45] 
2008 Ireland Yes No - Yes - - - No [42] 
2002 Canada Yes No - Yes - - - No [23] 
200? Japan Yes No - Yes - - - Yes [70] 
aPapers were assessed for methodology, pathogen species identified, and whether this identification could be viewed as definitive (based on the 431 
methods given). bEither correct tissue screened microscopically, or infection shown microscopically and species confirmed molecularly. 432 
cAbbreviations: -, species not screened for. 433 
